Literature DB >> 28273023

Dapivirine Vaginal Ring for HIV-1 Prevention.

Jared M Baeten1, Elizabeth R Brown2, Sharon L Hillier3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28273023     DOI： 10.1056/NEJMc1616546

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.

Authors:  Catherine A Chappell; Ishana Harkoo; Daniel W Szydlo; Katherine E Bunge; Devika Singh; Clemensia Nakabiito; Felix Mhlanga; Betty Kamira; Jeanna M Piper; Jennifer E Balkus; Sharon L Hillier
Journal:  Contraception       Date:  2019-06-19       Impact factor: 3.375

Review 2.  Topical Microbicides in HIV Prevention: State of the Promise.

Authors:  Jared M Baeten; Craig W Hendrix; Sharon L Hillier
Journal:  Annu Rev Med       Date:  2019-10-15       Impact factor: 13.739

Review 3.  The Influence of Cervicovaginal Microbiota on Mucosal Immunity and Prophylaxis in the Battle against HIV.

Authors:  Mara Farcasanu; Douglas S Kwon
Journal:  Curr HIV/AIDS Rep       Date:  2018-02       Impact factor: 5.071

4.  Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.

Authors:  Sinead Delany-Moretlwe; James P Hughes; Peter Bock; Samuel Gurrion Ouma; Portia Hunidzarira; Dishiki Kalonji; Noel Kayange; Joseph Makhema; Patricia Mandima; Carrie Mathew; Elizabeth Spooner; Juliet Mpendo; Pamela Mukwekwerere; Nyaradzo Mgodi; Patricia Nahirya Ntege; Gonasagrie Nair; Clemensia Nakabiito; Harriet Nuwagaba-Biribonwoha; Ravindre Panchia; Nishanta Singh; Bekezela Siziba; Jennifer Farrior; Scott Rose; Peter L Anderson; Susan H Eshleman; Mark A Marzinke; Craig W Hendrix; Stephanie Beigel-Orme; Sybil Hosek; Elizabeth Tolley; Nirupama Sista; Adeola Adeyeye; James F Rooney; Alex Rinehart; William R Spreen; Kimberly Smith; Brett Hanscom; Myron S Cohen; Mina C Hosseinipour
Journal:  Lancet       Date:  2022-04-01       Impact factor: 202.731

5.  Phase 1 Pharmacokinetic Trial of 2 Intravaginal Rings Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048.

Authors:  Albert Y Liu; Jingyang Zhang; Peter L Anderson; Theresa Wagner; Zhenyu Pan; Melissa Peda; Kailazarid Gomez; May Beamer; Cindy Jacobson; Julie Strizki; Charlene S Dezzutti; Jeanna M Piper
Journal:  Clin Infect Dis       Date:  2019-03-19       Impact factor: 9.079

6.  Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study.

Authors:  Jared M Baeten; Thesla Palanee-Phillips; Nyaradzo M Mgodi; Ashley J Mayo; Daniel W Szydlo; Gita Ramjee; Brenda Gati Mirembe; Felix Mhlanga; Portia Hunidzarira; Leila E Mansoor; Samantha Siva; Vaneshree Govender; Bonus Makanani; Logashvari Naidoo; Nishanta Singh; Gonasagrie Nair; Lameck Chinula; Urvi M Parikh; John W Mellors; Iván C Balán; Kenneth Ngure; Ariane van der Straten; Rachel Scheckter; Morgan Garcia; Melissa Peda; Karen Patterson; Edward Livant; Katherine Bunge; Devika Singh; Cindy Jacobson; Yuqing Jiao; Craig W Hendrix; Zvavahera M Chirenje; Clemensia Nakabiito; Taha E Taha; Judith Jones; Kristine Torjesen; Annalene Nel; Zeda Rosenberg; Lydia E Soto-Torres; Sharon L Hillier; Elizabeth R Brown
Journal:  Lancet HIV       Date:  2021-02       Impact factor: 12.767

7.  Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States.

Authors:  Albert Y Liu; Clara Dominguez Islas; Holly Gundacker; Blazej Neradilek; Craig Hoesley; Ariane van der Straten; Craig W Hendrix; May Beamer; Cindy E Jacobson; Tara McClure; Tanya Harrell; Katherine Bunge; Brid Devlin; Jeremy Nuttall; Patrick Spence; John Steytler; Jeanna M Piper; Mark A Marzinke
Journal:  J Int AIDS Soc       Date:  2021-06       Impact factor: 6.707
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.